Abnormal uterine bleeding: Difference between revisions
Jump to navigation
Jump to search
imported>Kataplan No edit summary |
|||
| Line 29: | Line 29: | ||
<!-- Cause --> | <!-- Cause --> | ||
The underlying causes may be structural or non-structural and are classified in accordance with the FIGO system 1 & 2.<ref name=" | The underlying causes may be structural or non-structural and are classified in accordance with the FIGO system 1 & 2.<ref name="Bac2017" /><ref name="Jain_2023">{{cite journal | vauthors = Jain V, Munro MG, Critchley HO | title = Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO Systems 1 and 2 | journal = International Journal of Gynaecology and Obstetrics | volume = 162 Suppl 2 | issue = Suppl 2 | pages = 29–42 | date = August 2023 | pmid = 37538019 | pmc = 10952771 | doi = 10.1002/ijgo.14946 }}</ref> Common causes include: [[Ovulation]] problems, [[Uterine fibroid|fibroids]], the [[Adenomyosis|lining of the uterus growing into the uterine wall]], [[uterine polyps]], underlying [[bleeding problems]], side effects from [[birth control]], or [[cancer]].<ref name="Bac2017" /> Susceptibility to each cause is often dependent on an individual's stage in life (''prepubescent, premenopausal, postmenopausal''). More than one category of causes may apply in an individual case.<ref name="Bac2017" /> The first step in work-up is to rule out a [[tumor]] or [[pregnancy]].<ref name="Bac2017" /><ref name="Che2017" /> Vaginal bleeding during pregnancy may be abnormal in certain circumstances. Please see [[Obstetrical bleeding]] and [[early pregnancy bleeding]] for more information. [[Medical imaging]] or [[hysteroscopy]] may help with the diagnosis.<ref name="Whit2016" /> | ||
<!-- Treatment and epidemiolgy --> | <!-- Treatment and epidemiolgy --> | ||
| Line 35: | Line 35: | ||
== Signs and symptoms == | == Signs and symptoms == | ||
Although uterine bleeding can be alarming and abnormal, there are many instances in which uterine bleeding is normal. ''FIGO System 1'' is the first part of the classification system developed by the [[International Federation of Gynaecology and Obstetrics|''International Federation of Gynecology and Obstetrics'']] to standardize the differences between normal uterine bleeding and abnormal uterine bleeding based on | Although uterine bleeding can be alarming and abnormal, there are many instances in which uterine bleeding is normal. ''FIGO System 1'' is the first part of the classification system developed by the [[International Federation of Gynaecology and Obstetrics|''International Federation of Gynecology and Obstetrics'']] to standardize the differences between normal uterine bleeding and abnormal uterine bleeding based on ''frequency, duration, regularity and individual flow volume''.<ref name="Jain_2023" /><ref name="Munro_2011">{{cite journal | vauthors = Munro MG, Critchley HO, Broder MS, Fraser IS | title = FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age | journal = International Journal of Gynaecology and Obstetrics | volume = 113 | issue = 1 | pages = 3–13 | date = April 2011 | pmid = 21345435 | doi = 10.1016/j.ijgo.2010.11.011 }}</ref> | ||
===Normal uterine bleeding=== | ===Normal uterine bleeding=== | ||
* Monthly Menstrual cycle occurring every 21 – 35 days. (''Most common cause of'' ''uterine bleeding'').<ref name="American College of Obstetricians and Gynecologists (ACOG)">{{Cite web |title=Abnormal Uterine Bleeding |url=https://www.acog.org/womens-health/faqs/abnormal-uterine-bleeding?utm_source=redirect&utm_medium=web&utm_campaign=otn |access-date=2025-03-13 | work = American College of Obstetricians and Gynecologists (ACOG) |language=en}}</ref> | * Monthly Menstrual cycle occurring every 21 – 35 days. (''Most common cause of'' ''uterine bleeding'').<ref name="American College of Obstetricians and Gynecologists (ACOG)">{{Cite web |title=Abnormal Uterine Bleeding |url=https://www.acog.org/womens-health/faqs/abnormal-uterine-bleeding?utm_source=redirect&utm_medium=web&utm_campaign=otn |access-date=2025-03-13 | work = American College of Obstetricians and Gynecologists (ACOG) |language=en}}</ref> | ||
* Neonatal uterine bleeding can occur in newborn females due to rapidly decreasing estrogen levels.<ref>{{cite journal | vauthors = Wróblewska-Seniuk K, Jarząbek-Bielecka G, Kędzia W | title = Gynecological Problems in Newborns and Infants | journal = Journal of Clinical Medicine | volume = 10 | issue = 5 | pages = 1071 | date = March 2021 | pmid = 33806632 | pmc = 7961508 | doi = 10.3390/jcm10051071 | doi-access = free }}</ref> | * Neonatal uterine bleeding can occur in newborn females due to rapidly decreasing estrogen levels.<ref>{{cite journal | vauthors = Wróblewska-Seniuk K, Jarząbek-Bielecka G, Kędzia W | title = Gynecological Problems in Newborns and Infants | journal = Journal of Clinical Medicine | volume = 10 | issue = 5 | pages = 1071 | date = March 2021 | pmid = 33806632 | pmc = 7961508 | doi = 10.3390/jcm10051071 | doi-access = free }}</ref> | ||
* Postpartum [[lochia]] is a bloody discharge that occurs post pregnancy and can last for several weeks.<ref>{{cite journal | vauthors = Oppenheimer LW, Sherriff EA, Goodman JD, Shah D, James CE | title = The duration of lochia | journal = British Journal of Obstetrics and Gynaecology | volume = 93 | issue = 7 | pages = 754–757 | date = July 1986 | pmid = | * Postpartum [[lochia]] is a bloody discharge that occurs post pregnancy and can last for several weeks.<ref>{{cite journal | vauthors = Oppenheimer LW, Sherriff EA, Goodman JD, Shah D, James CE | title = The duration of lochia | journal = British Journal of Obstetrics and Gynaecology | volume = 93 | issue = 7 | pages = 754–757 | date = July 1986 | pmid = 3755355 }}</ref> | ||
* Uterine procedures such as [[Biopsy|biopsies]], [[Uterine myomectomy|myomectomies]], [[intrauterine device]] insertion and [[Pap test|Pap smears]] can cause light bleeding that may last for several days. | * Uterine procedures such as [[Biopsy|biopsies]], [[Uterine myomectomy|myomectomies]], [[intrauterine device]] insertion and [[Pap test|Pap smears]] can cause light bleeding that may last for several days. | ||
===Abnormal uterine bleeding=== | ===Abnormal uterine bleeding=== | ||
<ref name="American College of Obstetricians and Gynecologists (ACOG)" /><ref name="Bradley_2016">{{cite journal | vauthors = Bradley LD, Gueye NA | title = The medical management of abnormal uterine bleeding in reproductive-aged women | journal = American Journal of Obstetrics and Gynecology | volume = 214 | issue = 1 | pages = 31–44 | date = January 2016 | pmid = 26254516 | doi = 10.1016/j.ajog.2015.07.044 }}</ref><ref name="Wouk_2019">{{cite journal | vauthors = Wouk N, Helton M | title = Abnormal Uterine Bleeding in Premenopausal Women | journal = American Family Physician | volume = 99 | issue = 7 | pages = 435–443 | date = April 2019 | pmid = | <ref name="American College of Obstetricians and Gynecologists (ACOG)" /><ref name="Bradley_2016">{{cite journal | vauthors = Bradley LD, Gueye NA | title = The medical management of abnormal uterine bleeding in reproductive-aged women | journal = American Journal of Obstetrics and Gynecology | volume = 214 | issue = 1 | pages = 31–44 | date = January 2016 | pmid = 26254516 | doi = 10.1016/j.ajog.2015.07.044 }}</ref><ref name="Wouk_2019">{{cite journal | vauthors = Wouk N, Helton M | title = Abnormal Uterine Bleeding in Premenopausal Women | journal = American Family Physician | volume = 99 | issue = 7 | pages = 435–443 | date = April 2019 | pmid = 30932448 }}</ref><ref name="Jain_2023"/> | ||
* Menstrual bleeding starts before 21 days or after 35 days | * Menstrual bleeding starts before 21 days or after 35 days | ||
* Menstrual bleeding that lasts more than 7 days | * Menstrual bleeding that lasts more than 7 days | ||
| Line 65: | Line 65: | ||
[[Postmenopausal]] group includes all persons with a uterus that have [[Menopause|stopped menstruation]] for more than one year or 12 consecutive months. Declining ovulatory function or menopause, is the most common cause of abnormal bleeding. Menstrual bleeding becomes gradually less frequent and lighter until it completely stops. Uterine cell wall thinning and overgrowth as well as cancer are common causes for abnormal uterine bleeding concern.<ref>{{cite journal | vauthors = Hernandez E | title = ACOG Practice Bulletin number 65: management of endometrial cancer | journal = Obstetrics and Gynecology | volume = 107 | issue = 4 | pages = 952; author reply 952-952; author reply 953 | date = April 2006 | pmid = 16582139 | doi = 10.1097/01.AOG.0000209463.53764.e7 }}</ref><ref name="Committee on Practice Bulletins—Gynecology_2012" /> | [[Postmenopausal]] group includes all persons with a uterus that have [[Menopause|stopped menstruation]] for more than one year or 12 consecutive months. Declining ovulatory function or menopause, is the most common cause of abnormal bleeding. Menstrual bleeding becomes gradually less frequent and lighter until it completely stops. Uterine cell wall thinning and overgrowth as well as cancer are common causes for abnormal uterine bleeding concern.<ref>{{cite journal | vauthors = Hernandez E | title = ACOG Practice Bulletin number 65: management of endometrial cancer | journal = Obstetrics and Gynecology | volume = 107 | issue = 4 | pages = 952; author reply 952-952; author reply 953 | date = April 2006 | pmid = 16582139 | doi = 10.1097/01.AOG.0000209463.53764.e7 }}</ref><ref name="Committee on Practice Bulletins—Gynecology_2012" /> | ||
The mechanisms, or reasons, that each of the PALM COEIN abnormalities cause uterine bleeding is not well understood, but the table below includes some scientific hypothesis and observations that give a strong indication of what may be happening.<ref name="Jain_2023" /><ref name="Munro_2011" /><ref name="Bradley_2016" /><ref name=" | The mechanisms, or reasons, that each of the PALM COEIN abnormalities cause uterine bleeding is not well understood, but the table below includes some scientific hypothesis and observations that give a strong indication of what may be happening.<ref name="Jain_2023" /><ref name="Munro_2011" /><ref name="Bradley_2016" /><ref name="Whit2016" /><ref name="Leal_2024" /> | ||
For more in-depth information about each of these causes, click on the links in the table below. | For more in-depth information about each of these causes, click on the links in the table below. | ||
| Line 79: | Line 79: | ||
|[[Endometrial polyp|Polyps]] | |[[Endometrial polyp|Polyps]] | ||
|<small>Condensed tissue overgrowths along the endometrial lining</small> <ref name="Jain_2023" /><ref name="Leal_2024" /><ref name="Marnach_2019" /> | |<small>Condensed tissue overgrowths along the endometrial lining</small> <ref name="Jain_2023" /><ref name="Leal_2024" /><ref name="Marnach_2019" /> | ||
|<small>Possibly due to [[stromal cell]] congestion that blocks normal blood flow leading to expulsion of excess blood through the uterus.</small> <ref name="Jain_2023" /><ref name="Marnach_2019">{{cite journal | vauthors = Marnach ML, Laughlin-Tommaso SK | title = Evaluation and Management of Abnormal Uterine Bleeding | journal = Mayo Clinic Proceedings | volume = 94 | issue = 2 | pages = 326–335 | date = February 2019 | pmid = 30711128 | doi = 10.1016/j.mayocp.2018.12.012 }}</ref><ref name="Leal_2024">{{cite journal | vauthors = Leal CR, Vannuccini S, Jain V, Dolmans MM, Di Spiezio Sardo A, Al-Hendy A, Reis FM | title = Abnormal uterine bleeding: The well-known and the hidden face | journal = Journal of Endometriosis and Uterine Disorders | volume = 6 | | |<small>Possibly due to [[stromal cell]] congestion that blocks normal blood flow leading to expulsion of excess blood through the uterus.</small> <ref name="Jain_2023" /><ref name="Marnach_2019">{{cite journal | vauthors = Marnach ML, Laughlin-Tommaso SK | title = Evaluation and Management of Abnormal Uterine Bleeding | journal = Mayo Clinic Proceedings | volume = 94 | issue = 2 | pages = 326–335 | date = February 2019 | pmid = 30711128 | doi = 10.1016/j.mayocp.2018.12.012 }}</ref><ref name="Leal_2024">{{cite journal | vauthors = Leal CR, Vannuccini S, Jain V, Dolmans MM, Di Spiezio Sardo A, Al-Hendy A, Reis FM | title = Abnormal uterine bleeding: The well-known and the hidden face | journal = Journal of Endometriosis and Uterine Disorders | volume = 6 | article-number = 100071 | date = June 2024 | pmid = 38764520 | pmc = 11101194 | doi = 10.1016/j.jeud.2024.100071 }}</ref> | ||
|- | |- | ||
|'''A''' | |'''A''' | ||
| Line 88: | Line 88: | ||
|'''L''' | |'''L''' | ||
|[[Leiomyoma|Leiomyoma (''Fibroids'')]] | |[[Leiomyoma|Leiomyoma (''Fibroids'')]] | ||
|<small>Non-cancerous smooth muscle cell tumors</small> <ref name="Jain_2023" /><ref name=" | |<small>Non-cancerous smooth muscle cell tumors</small> <ref name="Jain_2023" /><ref name="Whit2016" /><ref name="Leal_2024" /> | ||
|<small>Possibly due to increased vasculature (''blood vessels'') and surface area of uterine lining. Impaired angiogenesis and uterine blood clotting abilities may also contribute.<ref name=" | |<small>Possibly due to increased vasculature (''blood vessels'') and surface area of uterine lining. Impaired angiogenesis and uterine blood clotting abilities may also contribute.<ref name="Whit2016" /><ref name="Leal_2024" /><ref name="Jain_2023" /></small> | ||
|- | |- | ||
|'''M''' | |'''M''' | ||
|[[Uterine cancer|Malignancy (''Cancer'')]] | |[[Uterine cancer|Malignancy (''Cancer'')]] | ||
|<small>Uterine cancer & Endometrial hyperplasia</small> <ref name="Wouk_2019" /><ref name=" | |<small>Uterine cancer & Endometrial hyperplasia</small> <ref name="Wouk_2019" /><ref name="Whit2016" /><ref name="Marnach_2019" /> | ||
|<small>Most likely due to long-term exposure to estrogen without simultaneous exposure to progesterone.<ref name="Wouk_2019" /><ref name=" | |<small>Most likely due to long-term exposure to estrogen without simultaneous exposure to progesterone.<ref name="Wouk_2019" /><ref name="Whit2016" /><ref name="Marnach_2019" /></small> | ||
|- | |- | ||
! | ! | ||
| Line 103: | Line 103: | ||
|'''C''' | |'''C''' | ||
|[[Coagulopathy|Coagulopathies (''Clotting Disorders'')]] | |[[Coagulopathy|Coagulopathies (''Clotting Disorders'')]] | ||
|<small>Bleeding disorders impairing the body's blood clotting function. Microbial infection, renal and liver disease, and cancer also contribute.</small><ref name=" | |<small>Bleeding disorders impairing the body's blood clotting function. Microbial infection, renal and liver disease, and cancer also contribute.</small><ref name="Whit2016" /><ref name="Marnach_2019" /> | ||
|<small>Improper platelet function and blood clotting factor deficiencies impair uterine ability to create blood clots that prevent excess bleeding.<ref name="Marnach_2019" /><ref name=" | |<small>Improper platelet function and blood clotting factor deficiencies impair uterine ability to create blood clots that prevent excess bleeding.<ref name="Marnach_2019" /><ref name="Whit2016" /></small> | ||
|- | |- | ||
|'''O''' | |'''O''' | ||
| Line 112: | Line 112: | ||
|- | |- | ||
|'''E''' | |'''E''' | ||
|[ | |[[Endometrium#Diseases related with endometrium|Endometrial Disorders]] | ||
|<small>Impairment in function of cells that line the uterus that results in excessive bleeding.</small> <ref name="Jain_2023" /><ref name="Wouk_2019" /><ref name="Marnach_2019" /> | |<small>Impairment in function of cells that line the uterus that results in excessive bleeding.</small> <ref name="Jain_2023" /><ref name="Wouk_2019" /><ref name="Marnach_2019" /> | ||
|<small>Possibly due to vasoconstriction impairment, systemic inflammation or infections.<ref name="Jain_2023" /><ref name="Wouk_2019" /><ref name="Marnach_2019" /></small> | |<small>Possibly due to vasoconstriction impairment, systemic inflammation or infections.<ref name="Jain_2023" /><ref name="Wouk_2019" /><ref name="Marnach_2019" /></small> | ||
| Line 123: | Line 123: | ||
|'''N''' | |'''N''' | ||
|Not Otherwise Classified | |Not Otherwise Classified | ||
|<small>Rare impairments such as arteriovenous malformations, endometrial pseudoaneurysms (''due to postpartum caesarean scar''), myometrial hypertrophy and chronic endometritis.</small> <ref name="Jain_2023" /><ref name=" | |<small>Rare impairments such as arteriovenous malformations, endometrial pseudoaneurysms (''due to postpartum caesarean scar''), myometrial hypertrophy and chronic endometritis.</small> <ref name="Jain_2023" /><ref name="Whit2016" /><ref name="Marnach_2019" /> | ||
|<small>Irregular connections between arteries and veins in uterus lead to excess bleeding. Pocket of blood can form within uterine scar tissue post C-section.</small><ref name="Jain_2023" /><ref name="Marnach_2019" /><ref name=" | |<small>Irregular connections between arteries and veins in uterus lead to excess bleeding. Pocket of blood can form within uterine scar tissue post C-section.</small><ref name="Jain_2023" /><ref name="Marnach_2019" /><ref name="Whit2016" /> | ||
|} | |} | ||
==Diagnosis== | ==Diagnosis== | ||
| Line 163: | Line 162: | ||
{{Diseases of the pelvis and genitals}} | {{Diseases of the pelvis and genitals}} | ||
[[Category:Wikipedia Student Program]] | |||
[[Category:Uterus]] | |||
[[Category:Bleeding]] | |||
[[Category:Noninflammatory disorders of female genital tract]] | [[Category:Noninflammatory disorders of female genital tract]] | ||
[[Category:Wikipedia medicine articles ready to translate]] | [[Category:Wikipedia medicine articles ready to translate]] | ||
Latest revision as of 14:55, 18 October 2025
Template:Short description Template:Cs1 config Template:Infobox medical condition (new)
Abnormal uterine bleeding is vaginal bleeding from the uterus that is abnormally frequent, lasts excessively long, is heavier than normal, or is irregular.[1][2] The term "dysfunctional uterine bleeding" was used when no underlying cause was present.[2] Quality of life may be negatively affected.[3]
The underlying causes may be structural or non-structural and are classified in accordance with the FIGO system 1 & 2.[2][4] Common causes include: Ovulation problems, fibroids, the lining of the uterus growing into the uterine wall, uterine polyps, underlying bleeding problems, side effects from birth control, or cancer.[2] Susceptibility to each cause is often dependent on an individual's stage in life (prepubescent, premenopausal, postmenopausal). More than one category of causes may apply in an individual case.[2] The first step in work-up is to rule out a tumor or pregnancy.[2][5] Vaginal bleeding during pregnancy may be abnormal in certain circumstances. Please see Obstetrical bleeding and early pregnancy bleeding for more information. Medical imaging or hysteroscopy may help with the diagnosis.[3]
Treatment depends on the underlying cause.[2][3] Options may include hormonal birth control, gonadotropin-releasing hormone agonists, tranexamic acid, nonsteroidal anti-inflammatory drugs, and surgery such as endometrial ablation or hysterectomy.[1][5] Over the course of a year, roughly 20% of reproductive-aged women self-report at least one symptom of abnormal uterine bleeding.[3]
Signs and symptoms
Although uterine bleeding can be alarming and abnormal, there are many instances in which uterine bleeding is normal. FIGO System 1 is the first part of the classification system developed by the International Federation of Gynecology and Obstetrics to standardize the differences between normal uterine bleeding and abnormal uterine bleeding based on frequency, duration, regularity and individual flow volume.[4][6]
Normal uterine bleeding
- Monthly Menstrual cycle occurring every 21 – 35 days. (Most common cause of uterine bleeding).[7]
- Neonatal uterine bleeding can occur in newborn females due to rapidly decreasing estrogen levels.[8]
- Postpartum lochia is a bloody discharge that occurs post pregnancy and can last for several weeks.[9]
- Uterine procedures such as biopsies, myomectomies, intrauterine device insertion and Pap smears can cause light bleeding that may last for several days.
Abnormal uterine bleeding
- Menstrual bleeding starts before 21 days or after 35 days
- Menstrual bleeding that lasts more than 7 days
- Heavy menstrual cycle bleeding that necessitates changing pad or tampon roughly every hour (about 80 mL of blood loss) .
- Any bleeding between menstrual cycles, after sexual intercourse or bleeding after six months of menopause
- Premenopausal menstrual bleeding that stops for more than 3 months
Causes and mechanisms
The causes of abnormal uterine bleeding are divided into nine categories (PALM COEIN) under the FIGO System 2 which is the second part of the classification system developed by the International Federation of Gynecology and Obstetrics. More than one category of causes may apply in an individual case.[4][6]
Causes of abnormal uterine bleeding can also be narrowed down according to age group because each stage of life brings unique changes to an individual's uterine structure and systemic hormones.
Prepubescent group includes all persons with a uterus that have not yet started menstruation (monthly bleeding). Newborn uterine bleeding is a normal occurrence and should gradually stop as estrogen leaves the infant's body. Any bleeding outside of the newborn period is abnormal and should be investigated for a cause, including sexual abuse.[12][13]
Premenopausal group includes all persons with a uterus that have started and are currently experiencing menstruation.
- Adolescents between the ages of 13 and 19 commonly experience irregular menstrual cycles as their hormones and ovulation cycle regulates. Birth control, coagulopathies, pregnancy, abnormal uterine lining growths and infection are also common causes of abnormal bleeding in this age range.
- Adults between the ages of 20 and 40 most commonly experience abnormal uterine bleeding due to pregnancy and hormonal birth control. Uterine structural abnormalities (See PALM in chart below) ovulatory and endometrial dysregulation are also common causes. Uterine cancer is a rare cause of abnormal uterine bleeding in this group.[4][11][12]
Postmenopausal group includes all persons with a uterus that have stopped menstruation for more than one year or 12 consecutive months. Declining ovulatory function or menopause, is the most common cause of abnormal bleeding. Menstrual bleeding becomes gradually less frequent and lighter until it completely stops. Uterine cell wall thinning and overgrowth as well as cancer are common causes for abnormal uterine bleeding concern.[14][12]
The mechanisms, or reasons, that each of the PALM COEIN abnormalities cause uterine bleeding is not well understood, but the table below includes some scientific hypothesis and observations that give a strong indication of what may be happening.[4][6][10][3][15]
For more in-depth information about each of these causes, click on the links in the table below.
| Structural Causes | Description | How this Leads to Abnormal Bleeding | |
|---|---|---|---|
| P | Polyps | Condensed tissue overgrowths along the endometrial lining [4][15][16] | Possibly due to stromal cell congestion that blocks normal blood flow leading to expulsion of excess blood through the uterus. [4][16][15] |
| A | Adenomyosis | Endometrial tissue invades the uterine muscle causing enlargement [15][16][17] | Possibly due to reduction of hormone signaling in response to fibrotic lesions that invade the uterine muscle and cell wall lining meet.[15][17] Increased angiogenesis and immunological oxidative stress have also been implicated.[18][16] |
| L | Leiomyoma (Fibroids) | Non-cancerous smooth muscle cell tumors [4][3][15] | Possibly due to increased vasculature (blood vessels) and surface area of uterine lining. Impaired angiogenesis and uterine blood clotting abilities may also contribute.[3][15][4] |
| M | Malignancy (Cancer) | Uterine cancer & Endometrial hyperplasia [11][3][16] | Most likely due to long-term exposure to estrogen without simultaneous exposure to progesterone.[11][3][16] |
| Nonstructural Causes | Description of Cause | How this Leads to Abnormal Bleeding | |
| C | Coagulopathies (Clotting Disorders) | Bleeding disorders impairing the body's blood clotting function. Microbial infection, renal and liver disease, and cancer also contribute.[3][16] | Improper platelet function and blood clotting factor deficiencies impair uterine ability to create blood clots that prevent excess bleeding.[16][3] |
| O | Ovulatory Disorders | Conditions impairing the female body's ability to produce gametes (reproductive eggs). [4][19] | Possibly due to abnormal increases or decreases of reproductive hormones interrupt the ovulation cycle and prevent appropriate shedding and regeneration of the uterine lining.[19][4] |
| E | Endometrial Disorders | Impairment in function of cells that line the uterus that results in excessive bleeding. [4][11][16] | Possibly due to vasoconstriction impairment, systemic inflammation or infections.[4][11][16] |
| I | Iatrogenic (Medical Errors) | Bleeding caused by medications or medical procedures. Hormone therapy (contraceptive and non contraceptive) is the most common cause. [11][15][16] | Medications and IUD insertions can possibly cause disruption in hormonal regulation of cell wall repair, inflammatory response and blood vessel system of the endometrium. [11][15][16] |
| N | Not Otherwise Classified | Rare impairments such as arteriovenous malformations, endometrial pseudoaneurysms (due to postpartum caesarean scar), myometrial hypertrophy and chronic endometritis. [4][3][16] | Irregular connections between arteries and veins in uterus lead to excess bleeding. Pocket of blood can form within uterine scar tissue post C-section.[4][16][3] |
Diagnosis
Diagnosis of abnormal uterine bleeding starts with a medical history and physical examination.[3] Normal menstrual bleeding patterns vary from woman to woman, so the medical history covers specific details about the woman's individual menstrual bleeding pattern, such as its predictability, length, volume, and whether she experiences cramps or other pain. The healthcare provider will also check to see whether she or any family members have any potentially related health conditions, and whether she is taking medication that might increase or decrease menstrual bleeding, such as herbal supplements, hormonal contraceptives, over-the-counter drugs such as aspirin, or blood thinners.[20]
Medical tests include a blood test, to see whether the abnormal bleeding has caused anemia, and a pelvic ultrasound, to see whether the abnormal bleeding is caused by a structural problem, such as a uterine fibroid.[3] Ultrasound is specifically recommended in those over the age of 35 or those in whom bleeding continues despite initial treatment.[21] Laboratory assessment of thyroid stimulating hormone (TSH), pregnancy, and chlamydia is also recommended.[20]
More extensive testing might include magnetic resonance imaging and endometrial sampling.[3] Endometrial sampling is recommended in those over the age of 45 who do not improve with treatment and in those with intermenstrual bleeding that persists.[3] The PALM-COEIN system may be used to classify the uterine bleeding.[20]
Management
Treatment depends on the underlying cause.[2][3] Options may include hormonal birth control, gonadotropin-releasing hormone (GnRH) agonists, tranexamic acid, nonsteroidal anti-inflammatory drugs, and surgery such as endometrial ablation or hysterectomy.[1][5] Polyps, adenomyosis, and cancer are generally treated by surgery.[3] Iron supplementation may be needed.[3]
Terminology
The terminology "dysfunctional uterine bleeding" is no longer recommended.[2] Historically dysfunctional uterine bleeding meant there was no structural or systemic problems present.[2] In abnormal uterine bleeding underlying causes may be present.[2]
Epidemiology
About one-third of all medical appointments with gynecologists involve abnormal uterine bleeding, with the proportion rising to 70% in the years around menopause.[20]
References
<templatestyles src="Reflist/styles.css" />
- ↑ a b c Script error: No such module "citation/CS1".
- ↑ a b c d e f g h i j k Script error: No such module "Citation/CS1".
- ↑ a b c d e f g h i j k l m n o p q r s t Script error: No such module "Citation/CS1".
- ↑ a b c d e f g h i j k l m n o p Script error: No such module "Citation/CS1".
- ↑ a b c Script error: No such module "Citation/CS1".
- ↑ a b c Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ a b c d e f g h Script error: No such module "Citation/CS1".
- ↑ a b c Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b c d e f g h i Script error: No such module "Citation/CS1".
- ↑ a b c d e f g h i j k l m n Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "Citation/CS1".
- ↑ a b c d Script error: No such module "Citation/CS1".
- ↑ Cite error: Script error: No such module "Namespace detect".Script error: No such module "Namespace detect".
Script error: No such module "Check for unknown parameters".
External links
- Merck Manual Abnormal Uterine Bleeding